Similar Papers

Paper Title
Journal
Date
Author
Abstract 4721: Enhancement of doxorubicin cytotoxicity by histone deacetylase inhibition in human sarcoma cells
Maria Grazia Tupone ... Daniela Trisciuoglio
Cancer Research | VOL. 76
Maria Grazia Tupone, et. al.Maria Grazia Tupone ... Daniela Trisciuoglio
15 Jul 2016
Histone Deacetylase Inhibitors with or without AKT Inhibition Potentially Increase the Efficacy of Daratumumab in Multiple Myeloma By Enhancing the Antibody-Dependent Cell-Mediated and Complement-Dependent Cytotoxicity As Well As Apoptosis
Mitsuhito Hirano ... Arinobu Tojo
Blood | VOL. 132
Mitsuhito Hirano, et. al.Mitsuhito Hirano ... Arinobu Tojo
29 Nov 2018
Death by HDAC Inhibition in Synovial Sarcoma Cells.
Aimée N Laporte ... Jared J Barrott
Molecular Cancer Therapeutics | VOL. 16
Aimée N Laporte, et. al.Aimée N Laporte ... Jared J Barrott
01 Dec 2017
Data from Death by HDAC Inhibition in Synovial Sarcoma Cells
Alireza Lorzadeh ... Torsten O Nielsen
-
Alireza Lorzadeh, et. al.Alireza Lorzadeh ... Torsten O Nielsen
03 Apr 2023
View more papers

More From: European Journal of Cancer

Paper Title
Journal
Date
Author
Editorial Board
-
European Journal of Cancer | VOL. 216
--
01 Feb 2025
Assessment of bone mineral density in men with de novo metastatic castration-sensitive prostate cancer treated with or without abiraterone acetate plus prednisone in the PEACE-1 phase 3 trial
Guilhem Roubaud ... Karim Fizazi
European Journal of Cancer | VOL. -
Guilhem Roubaud, et. al.Guilhem Roubaud ... Karim Fizazi
01 Feb 2025
A First-in-Human Phase 1/2 Dose-Escalation Study of MAK683 (EED Inhibitor) in Patients with Advanced Malignancies
Vincent Ribrag ... Zev A Wainberg
European Journal of Cancer | VOL. 216
Vincent Ribrag, et. al.Vincent Ribrag ... Zev A Wainberg
01 Feb 2025
Editorial Board
-
European Journal of Cancer | VOL. 217
--
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.